Literature DB >> 22735763

Polycystic kidney disease: An early urea-selective urine-concentrating defect in ADPKD.

Lise Bankir1, Daniel G Bichet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22735763     DOI： 10.1038/nrneph.2012.139

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Urinary diagnostic indices in acute renal failure: a prospective study.

Authors:  T R Miller; R J Anderson; S L Linas; W L Henrich; A S Berns; P A Gabow; R W Schrier
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

Review 2.  Imaging for the prognosis of autosomal dominant polycystic kidney disease.

Authors:  Kyongtae T Bae; Jared J Grantham
Journal:  Nat Rev Nephrol       Date:  2010-02       Impact factor: 28.314

Review 3.  New insights into urea and glucose handling by the kidney, and the urine concentrating mechanism.

Authors:  Lise Bankir; Baoxue Yang
Journal:  Kidney Int       Date:  2012-03-28       Impact factor: 10.612

4.  Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation.

Authors:  Thien Anh Ho; Nathalie Godefroid; Damien Gruzon; Jean-Philippe Haymann; Céline Maréchal; Xueqi Wang; Andreas Serra; Yves Pirson; Olivier Devuyst
Journal:  Kidney Int       Date:  2012-06-20       Impact factor: 10.612

Review 5.  Urea and urine concentrating ability: new insights from studies in mice.

Authors:  Baoxue Yang; Lise Bankir
Journal:  Am J Physiol Renal Physiol       Date:  2005-05

Review 6.  Potential deleterious effects of vasopressin in chronic kidney disease and particularly autosomal dominant polycystic kidney disease.

Authors:  E Meijer; W E Boertien; R Zietse; R T Gansevoort
Journal:  Kidney Blood Press Res       Date:  2011-06-21       Impact factor: 2.687

7.  Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.

Authors:  Debbie Zittema; Wendy E Boertien; André P van Beek; Robin P F Dullaart; Casper F M Franssen; Paul E de Jong; Esther Meijer; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 8.237

Review 8.  Renal prostaglandin synthesis. Sites of production and specific actions of prostaglandins.

Authors:  D Schlondorff
Journal:  Am J Med       Date:  1986-08-25       Impact factor: 4.965

Review 9.  Urea transporters and renal function: lessons from knockout mice.

Authors:  Robert A Fenton
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-09       Impact factor: 2.894

10.  The fractional excretion of urea: a new diagnostic test for acute renal allograft rejection.

Authors:  H E Corey; I Greifer; S M Greenstein; V Tellis; A Spitzer
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714
  10 in total
  7 in total

Review 1.  Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

Review 2.  Functional Reserve of the Kidney.

Authors:  Armando Armenta; Magdalena Madero; Bernardo Rodriguez-Iturbe
Journal:  Clin J Am Soc Nephrol       Date:  2021-11-10       Impact factor: 8.237

3.  Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients.

Authors:  Debbie Zittema; Else van den Berg; Esther Meijer; Wendy E Boertien; Anneke C Muller Kobold; Casper F M Franssen; Paul E de Jong; Stephan J L Bakker; Gerjan Navis; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 8.237

Review 4.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

5.  Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression.

Authors:  Judith E Heida; Ron T Gansevoort; A Lianne Messchendorp; Esther Meijer; Niek F Casteleijn; Wendy E Boertien; Debbie Zittema
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-27       Impact factor: 8.237

6.  Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.

Authors:  Debbie Zittema; Niek F Casteleijn; Stephan J L Bakker; Lianne S M Boesten; A A Margreeth Duit; Casper F M Franssen; Carlo A J M Gaillard; Ron T Gansevoort
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

7.  Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial.

Authors:  Jessica M Sontrop; Shi-Han Huang; Amit X Garg; Louise Moist; Andrew A House; Kerri Gallo; William F Clark
Journal:  BMJ Open       Date:  2015-11-24       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.